Combination of pegylated liposomal doxorubicin and docetaxel as neoadjuvant therapy for breast cancer with axillary lymph node metastasis

OBJECTIVE: To evaluate the efficacy and safety of the combination of pegylated liposomal doxorubicin and docetaxel as neoadjuvant therapy for breast cancer (BC) in patients with axillary lymph node metastasis. METHODS: In this single-arm study, 91 patients with clinical stage IIA–IIIc breast cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Li, Hong, Yang, Ma, Jie, Han, Meng, Zhang, Shuo, Shan, Baoen, Liu, Yunjiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Prospective Clinical Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418263/
https://www.ncbi.nlm.nih.gov/pubmed/32776809
http://dx.doi.org/10.1177/0300060520944310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418263/
https://www.ncbi.nlm.nih.gov/pubmed/32776809
http://dx.doi.org/10.1177/0300060520944310

Ejemplares similares